Emory and CDC team running HIV clinical trials
Emory-CDC CTU
This program runs clinical trials testing new HIV vaccines, prevention tools, and treatments for adults, pregnant people, adolescents, and children.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11410962 on NIH RePORTER |
What this research studies
You would visit one of Emory and CDC’s clinical sites to join studies of HIV prevention (including vaccines), treatment approaches, and care for related infections and conditions. The unit includes multiple clinical research sites and is expanding to a new site in Mexico City to include more diverse participants. Trials aim to enroll adults, pregnant people, adolescents, and children and prioritize including women and minorities. The team works with NIH networks and CDC partners so studies can start quickly as new research questions arise.
Who could benefit from this research
Good fit: Ideal candidates are people living with HIV or people at risk for HIV, including adults, pregnant people, adolescents, and children who meet specific trial eligibility criteria.
Not a fit: People who are neither living with nor at risk for HIV or who do not meet individual study eligibility criteria would generally not benefit from participating.
Why it matters
Potential benefit: If successful, this program could bring new HIV vaccines, prevention tools, or improved treatments into wider use and expand trial access for underrepresented groups.
How similar studies have performed: Previous HIV vaccine, prevention, and treatment trials have produced important advances while some vaccine strategies remain experimental and results have varied.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Kelley, Colleen F — Emory University
- Study coordinator: Kelley, Colleen F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.